IRIS
VIVIANI, GIORGIO LUCIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.569
Totale 8.569
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.569
Totale 8.569
Salva come PNG Salva come JPEG
Città #
Genova 6.755
Rapallo 1.003
Genoa 790
Bordighera 21
Totale 8.569
Salva come PNG Salva come JPEG
Nome #
CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke. 150
Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus 147
Insulin primes human neutrophils for CCL3-induced migration: crucial role for JNK 1/2. 146
N-Acetyl-L-Cysteine Prevents Effects Of Pentosidine on the Pancreatic Beta-Cell Line HIT-T15 143
Water distribution in insulin-dependent diabetes mellitus in various states of metabolic control. 140
An emerging role of glucagon-like Peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes. 139
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques. 137
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 136
Effects of valsartan therapy on protein glycoxidation. 133
Impairment of central motor conduction in diabetic patients. 132
Update on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic Myocardium. 131
Glucagon-Like Peptide-1 Secreting Cell Function as well as Production of Inflammatory Reactive Oxygen Species Is Differently Regulated by Glycated Serum and High Levels of Glucose. 131
Statins in the treatment of acute ischemic stroke. 131
Influence of cell age and ketoaminic linkage on rapid glycosylation of hemoglobin in human red cells in vitro. 129
New evidence for nicotinic acid treatment to reduce atherosclerosis. 128
Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15 126
Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome. 125
Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus. 121
Role of cytokines and chemokines in non-alcoholic fatty liver disease. 119
Update on the Protective Molecular Pathways Improving Pancreatic Beta-Cell Dysfunction. 119
An instrument for real-time spectral estimation of heart rate variability signals. 118
Exploration of the early insulin response by two small successive loads of I.V. glucose in normal and obese subjects. 116
null 116
Advanced Glycation End Products Play Adverse Proinflammatory Activities in Osteoporosis. 114
Evidence for the Gut Microbiota Short-Chain Fatty Acids as Key Pathophysiological Molecules Improving Diabetes. 114
Advanced glycation endproducts and diabetes. Beyond vascular complications. 114
Glucagon-Like Peptide-1 Triggers Protective Pathways in Pancreatic Beta-Cells Exposed to Glycated Serum. 112
I.V. glucose tolerance test: correlation between FFA, glucose and IRI in normal, obese and diabetic subjects. 112
Advanced Glycation End-products affect subcellular localization of the transcription factors regulating insulin gene transcription. 111
Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. 111
P87 Effect of exenatide, sitagliptin and vildagliptin on IGF-I in diabetic patients 108
Lercanidipine in type II diabetic patients with mild to moderate arterial hypertension. 108
Glucagon-like peptide-1 counteracts the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T15. 107
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 106
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. 105
Retinal Pigment Epithelial Cells Express a Functional Receptor for Glucagon-Like Peptide-1 (GLP-1). 104
Reduced glucose effectiveness as a feature of glucose intolerance evidence in elderly type-2 diabetic subjects. 103
Bcl-2 family and caspase-3 gene expression in fas-mediated apoptosis of isolated rat islets. 101
Analysis of non-fibroblastic interstitial cells of human pancreas. 99
Effects on glycation of Valsartan therapy in vivo. 98
Response to anti-VEGF-A treatment of retinal pigment epithelial cells in vitro. 98
Response to anti-VEGF-A treatment of endothelial cells in vitro 98
RANKL/OPG pathway is a promising target to reduce atherosclerosis plaque calcification. 97
Effetti degli AGEs sulla Linea Cellulare HIT-T15 Insulino-secernente 93
Advanced Glycation End-Products and Hyperglycemia Increase Angiopoietin-2 Production by Impairing Angiopoietin-1-Tie-2 System 88
Effect of nicotinic acid associated with retinol and tocopherols on plasma lipids in hyperlipoproteinaemic patients. 87
GLP-1 PREVENTS AGEs-INDUCED PANCREATIC BETA CELL DYSFUNCTION. 86
Isolation of pig pancreatic islets by a new method with hydraulic shaking 85
A method for erythrocyte filtration. 85
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials 83
Prednisolone protects pancreatic B-cells agaist cyclosporine and azathioprine effects. 82
RETINAL PIGMENT EPITHELIAL CELLS EXPRESS A FUNCTIONAL RECEPTOR FOR GLUCAGON-LIKE PEPTIDE-1. 79
Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials. 79
Indipendence of morphological and functional aspects of pseudoislets from gel collagen matrix. cell 78
[Psychological aspects in the therapy of diabetes]. 78
Pioglitazone attenuates the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T15. 77
Repaglinide-metformin combination in the treatment of type 2 diabetes: Comparison between three different combination regimens. 76
Oral tolerance and allograft: can multiple oral administrations of low doses of highly purified islets induce periferal tolerance in pancreatic islets allograft? 75
Application of the hydraulic shaking system to isolation of human pancreatic islets 75
Caveolin-1 is essential for glimepiride-induced insulin secretion in the pancreatic betaTC-6 cell line 72
Glycated serum decrease insulin secretion of the pancreatic beta cell line HIT-T15 71
The cannabinoid receptor type 2 is down-regulated in downstream portions of human carotid plaques. 70
Azathioprine decreases insulin secretion in human islets. 70
Receptor activator of NF-kappa B ligand (RANKL) increases neutrophilic degranulation and potentially associated cardiovascular risk. 69
Long-term follow-up of human islet autotransplantation. 69
In beta-TC cells nicotinamide prevents IL-1 beta-induced apoptosis blocks caspase-3 activation and up-regulates Bcl-2 69
Glycated FBS affects the viability of an insulin-secreting cell line in vitro. 68
Effects of advanced glycation end-products on GLP-1 secreting cells 67
Differente effetto ossidativo indotto da pentosidina e siero glicato ed efficacia del trattamento antiossidante con N-acetilcisteina su linee HIT-T15 e ARPE-19 66
Type 2 diabetes in elderly: assessment and treatment. A review and personal observational data (part II). 66
GLUCOSE INTERORGAN EXCHANGE IN CHRONIC RENAL FAILURE 64
Vascular endothelial growth factor-C secretion is increased by advanced glycation end-products: possible implication in ocular neovascularization 64
Regulation of VEGF by pentosi dine and glycated serum 63
Prevention of rejection and fibrosis: considerations in 25 patients. 62
I problemi dell'anziano con un piede diabetico 57
Correlations between NEFA and ketone bodies in normal and diabetic subjects. 57
Insulin response and NEFA behavior in volunteers with a flat response to oral glucose tolerance test. 57
[NEFA behavior and its correlations with IRI during IVGTT in normal, obese and diabetic subjects]. 56
Correlations between gamma-glutamyl-transpeptidase, triglycerides and cholesterol in normal, obese and diabetic subjects. 56
Islet autotransplantation in humans--a model for allotransplantation. 55
Oxidative stress, homocysteine and platelet function in NIDDM patients 55
L'approccio clinico-terapeutico al paziente diabetico anziano nelle diverse realtà assistenziali: revisione della letteratura ed esperienza personale (Seconda parte) 55
Double test of insulin sensitivity in normal and obese subjects. 54
Glycated Serum Decreases Insulin Content and Modifies the Expression of Proteins Involved in Insulin Granule Exocytosis. 54
[Pathology of the periodontium in diabetes mellitus: possible pathogenetic correlations and therapeutic indications]. 52
Differential effects of insulin on glycemia, NEFA and ketone bodies in diabetic subjects. 52
Cardiac function in the insulin-dependent juvenile diabetic: evaluation with echocardiography, polygraphy and dynamic electrocardiography. 51
[Non-insulin-dependent diabetes mellitus in the young]. 50
Rat serum improves rat pseudoislet formation and insulin gene expression. 50
Special aspects of the curve of the oral glucose tolerance test. 49
Effects of pindolol in insulin secretion. II. OGTT changes after pindolol therapy. 49
Effects of normoglycemia after a low carbohydrate diet in NIDDM. Insulin secretion and effectiveness. 48
Effects of pindolol on insulin secretion. I. Insulin response to small intravenous loads of glucose and to pindolol infusion. 47
Examination of the early phase of insulin secretion with 3 successive small overloads of glucose (5 g) in normal and obese subjects. 46
[Insulin secretion and hepatic extraction in juvenile non-insulin-dependent diabetes]. 41
[Left ventricular diastolic function in type I diabetes. A longitudinal echocardiographic study]. 40
null 29
Serum osteopontin predicts glycaemic profile improvement in metabolic syndrome: A pilot study 25
MiR-126 Mimic Counteracts the Increased Secretion of VEGF-A Induced by High Glucose in ARPE-19 Cells 8
Pathophysiological role of inflammatory molecules in paediatric ischaemic brain injury. 3
Totale 8.645
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.573
article - articoli 19.750
book - libri 0
conference - conferenze 1.823
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.146
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.482 90 46 125 182 223 244 372 163 214 434 288 101
2020/2021568 44 54 29 55 29 33 40 57 69 74 37 47
2021/20221.174 37 78 40 180 56 90 83 265 34 117 35 159
2022/20231.215 115 77 13 114 231 210 0 91 224 9 109 22
2023/2024598 24 89 7 69 56 120 30 29 35 17 41 81
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 8.645